Netherlands: Barentz announces strategic investment from Cinven to accelerate global expansion
Barentz, a leading provider of ingredients in the global market for human nutrition, pharmaceuticals, personal care and animal nutrition, announces today that Cinven has agreed to invest in their company. Cinven is a leading international private equity firm focused on building world-class European and global companies.
- Barentz has a strong market position in a structurally growing market for life science ingredients
- The Cinven team knows the speciality ingredients distribution market well
- Cinven recognizes the opportunities for both organic and buy and build growth
- Financial terms of the transaction are not disclosed
Headquartered in the Netherlands, Barentz distributes ingredients and additives for products to both small, medium and large customers globally. The company sources branded speciality ingredients from manufacturers worldwide. Through its active production facilities in Europe, North America and Asia, Barentz’ ingredient experts provide value-added technical support including pre-mixing, blending, ingredient formulation and ingredient testing.
Considering the distribution business is a structurally growing market, Barentz wants to continue to expand in order to serve their suppliers and customers on a global scale.
Hidde van der Wal, CEO of Barentz, commented:
‘We are delighted to be working with Cinven on the next phase of our growth. The Cinven team has really impressed us with their understanding of our market and their strong track record of growing businesses internationally.’
‘In particular, their investment and support for our business strategy will enable us to expand our operations into new geographic markets, including through acquisition, and will ensure we have the right infrastructure to achieve this.’
Ben Osnabrug, partner at Cinven, said:
‘Barentz has a strong presence in a structurally growing market. The Cinven team knows the speciality distribution sector well, with the key trends driving the growth of the food and life sciences ingredients market including a shift towards natural ingredients, increased demand for customised formulations, and a growing share of manufacturers using distributors to drive market access and to improve efficiencies.’
‘Cinven’s investment in Barentz resulted from a combination of our detailed sub-sector approach within Business Services, and our regional network in the Netherlands, and we are delighted to invest in this primary opportunity. In particular, Barentz has an excellent management team whom we can back to pursue both organic and buy and build growth.’
Search ADVOC News
Have you registered yet? 👋 https://t.co/9wn3eDwPYE
After thorough investigations by the firm’s internal private investigators, our Anti-Counterfeiting Team recently c… https://t.co/1xY9ZZZ91b
In providing their services, OFIs must consider the risk posed by any one or combination of the following elements:… https://t.co/UPnAlEYNZf
can manage and mitigate money laundering and terrorism financing risks. OFIs are required to identify sources of… https://t.co/J5Bx6sZ0wA
The Central Bank of Nigeria (“CBN”) Guidance Notes on Anti-Money Laundering and Combating the Financing of Terroris… https://t.co/FedgrmSsrT
The potential for AI to reshape the field of healthcare, to aid in diagnosis and enable a more personalized precisi… https://t.co/sDyYRSD6zd
and how patients are treated, but it will also optimize resource allocation, allowing health systems to function mo… https://t.co/Y7ZFRYO40d